Translating Cardiac Surgery and Cardiovascular Expertise
With a successful consulting track record in CE marks, IP, product development and patents specifically in cardiovascular, Myra Medical takes this expertise next level in sourcing and securing innovative products for distribution in the Swiss market
Dedicated Exclusively to the Swiss Market
Founded in 2014, Myra Medical is based in Canton Vaud and has been serving the Swiss market in securing novel and innovative products, including CE approval and clinical trials
Translatable Expertise in Cardiovascular
With a keen eye for disruptive technology and acquiring approval for cardiovascular medical devices, Myra Medical is best positioned to add value in the everyday clinical setting
Passionate on Doing What It Takes
Ensuring the Swiss market has access to innovative products is a priority, we have created other start ups dedicated to delivering advance technologies for interventional cardiovascular
With deep knowledge in cardiac surgery product development and patents, Myra Medical is focused on finding innovative cardiac surgery solutions. With the Coronéo Aortic Ring and Altius ProActiv+ 7 Lumen CVC Catheter currently in the product portfolio, we continue our search for partnerships for cutting edge technologies to deliver exclusively to the Swiss market.
Continuum of care is important to us, ensuring the patient has access to innovative solutions from surgery, to critical care and during recovery. With the Kimal CVC Catheter portfolio, Wexler Surgical Instruments and the Bedal Drainpatch, we offer clinicians novel solutions in decreasing infection risk and increase ease of use.
Novel companies find novel solutions and embrace stretching their expertise in new therapeutic areas. With the acquisition of the distribution rights of HM Cast in the Swiss Market, Myra Medical applies their knowledge of bringing innovative solutions to market to the Orthopedics arena.